Article: O bezopasnosti primeneniia nazal'nykh dekongestantov v pediatricheskoĭ praktike.
2018 Volume 83, Issue 2, Page(s) 46–50
Abstract: Undesirable effects of the application of the intransal vasoconstricting medications are a frequent occurrence in the pediatric practice. The objective of the present study was to evaluate the role of the intranasal vasoconstricting medications in the ... ...
Title translation | About the safety of application of nasal decongestants in the practice of pediatricians. |
---|---|
Abstract | Undesirable effects of the application of the intransal vasoconstricting medications are a frequent occurrence in the pediatric practice. The objective of the present study was to evaluate the role of the intranasal vasoconstricting medications in the structure of the means and methods currently available for the treatment of toxicological pathologies based at a multi-field clinical hospital. The retrospective analysis of the medical histories of the patients admitted to the toxicological department and annual reports for the period from 2015 to 2016 was undertaken. The study has demonstrated that intoxication associated with the use of the intranasal vasoconstricting medications was the most common cause of hospitalization of the children in the toxicological departments. Intoxication of this origin accounted for 15-20% of the total number of toxicological pathologies among the children. The cases of intoxication are most frequently documented in the group of children at the age between 1 and 3 years. The risk of the undesirable serious complications is especially high after the application of naphazoline-based intranasal vasoconstricting medications (71.7-77.4% of all the cases of intoxication with these products). It is concluded that the use of intranasal vasoconstricting medications in the pediatric practice should be carried out under the strict control, with the naphazoline-based preparations being totally excluded from the application. |
MeSH term(s) | Administration, Intranasal/methods ; Chemically-Induced Disorders/diagnosis ; Chemically-Induced Disorders/etiology ; Chemically-Induced Disorders/prevention & control ; Child, Preschool ; Female ; Humans ; Infant ; Male ; Naphazoline/administration & dosage ; Naphazoline/adverse effects ; Nasal Decongestants/administration & dosage ; Nasal Decongestants/adverse effects ; Nasal Obstruction/drug therapy ; Nasal Obstruction/epidemiology ; Retrospective Studies ; Risk Assessment ; Russia/epidemiology |
Chemical Substances | Nasal Decongestants ; Naphazoline (H231GF11BV) |
Language | Russian |
Publishing date | 2018-05-17 |
Publishing country | Russia (Federation) |
Document type | Journal Article |
ZDB-ID | 124096-1 |
ISSN | 0042-4668 |
ISSN | 0042-4668 |
DOI | 10.17116/otorino201883246-50 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.B 978: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.